World's Best Scientists 2026 revealed!

Jörg C. Prinz publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jörg C. Prinz sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

The last bar groups every scientist with 807 publications or more.

Jörg C. Prinz D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jörg C. Prinz sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

The last bar groups every scientist with 157 D-Index or more.

Overview

Jörg C. Prinz is affiliated with Ludwig-Maximilians-Universität München in Germany and has contributed extensively to the field of medicine, with a strong focus on ophthalmology. Their research portfolio includes significant work in glaucoma, retinal disorders, and corneal surgery, supplemented by studies in neurology and radiology.

Their research topics emphasize:

  • Glaucoma and retinal disorders
  • Corneal surgery and disorders
  • Retinal diseases and treatments
  • Corneal surgery and treatments
  • Neurological disorders and treatments
  • Intraocular surgery and lenses
  • Ophthalmology and eye disorders

Jörg C. Prinz has published in several respected venues, with frequent contributions to:

  • Klinische Monatsblätter für Augenheilkunde
  • Graefe's Archive for Clinical and Experimental Ophthalmology
  • PLoS ONE
  • Journal of Investigative Dermatology
  • Journal of the European Academy of Dermatology and Venereology

Their notable papers include:

  • Efficacy of citicoline as a supplement in glaucoma patients: A systematic review, 2023, PLoS ONE
  • The Impact of Aging on the Function of Retinal Ganglion Cells, 2024, Klinische Monatsblätter für Augenheilkunde
  • Influence of Covid-19 vaccination on immune-mediated skin diseases, 2022, Journal of the European Academy of Dermatology and Venereology
  • Efficacy of Ginkgo biloba on parameters in glaucoma: A systematic review, 2025, PLoS ONE
  • Effects of graft detachment on the central corneal thickness after uncomplicated Descemet membrane endothelial keratoplasty, 2024, Graefe's Archive for Clinical and Experimental Ophthalmology

Their frequent collaborators include:

  • Matthias Fuest
  • Verena Prokosch
  • Peter Walter
  • David Kuerten
  • Claus Cursiefen

The main fields of study represented in their work focus primarily on medicine, with 37 publications. Subfields include ophthalmology (17 publications), radiology, nuclear medicine and imaging (11 publications), neurology (4 publications), pediatrics, perinatology and child health (2 publications), and pathology and forensic medicine (2 publications).

Best Publications

  • Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions

    Batya B. Davidovici;Naveed Sattar;Prinz C. Jörg;Luis Puig

  • Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease

    Kamran Ghoreschi;Peter Thomas;Susanne Breit;Martin Dugas

  • Melanocyte antigen triggers autoimmunity in human psoriasis

    Akiko Arakawa;Katherina Siewert;Julia Stöhr;Petra Besgen

  • Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE).

    A. Blauvelt;J.C. Prinz;A.B. Gottlieb;K. Kingo

  • A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis.

    Kenneth B. Gordon;Kristina Callis Duffin;Robert Bissonnette;Jörg C. Prinz

  • Induction of Fc epsilon R2/CD23 on human epidermal Langerhans cells by human recombinant interleukin 4 and gamma interferon.

    T Bieber;A Rieger;C Neuchrist;J C Prinz

  • IgE-dependent antigen focusing by human B lymphocytes is mediated by the low-affinity receptor for IgE

    Pirron U;Schlunck T;Prinz Jc;Rieber Ep

  • The role of IL-23 and the IL-23/TH17 immune axis in the pathogenesis and treatment of psoriasis

    G Girolomoni;R Strohal;L Puig;H Bachelez;H Bachelez

  • Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasis.

    J. Prinz;O. Braun-Falco;M. Meurer;P. Daddona

  • IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes

    Mark Peric;Sarah Koglin;Song Min Kim;Shin Morizane

  • The role of T cells in psoriasis.

    JC Prinz

  • T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products.

    Prinz Jc;Gross B;Vollmer S;Trommler P

  • T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells.

    Sigrid Vollmer;Antje Menssen;Paul Trommler;Dolores Schendel

  • Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris.

    A Menssen;P Trommler;S Vollmer;D Schendel

  • Vitamin D Analog Calcipotriol Suppresses the Th17 Cytokine–Induced Proinflammatory S100 “Alarmins” Psoriasin (S100A7) and Koebnerisin (S100A15) in Psoriasis

    Zuzana Hegyi;Stephanie Zwicker;Daniela Bureik;Mark Peric

  • German evidence-based guidelines for the treatment of Psoriasis vulgaris (short version).

    Alexander Nast;Ina B. Kopp;Matthias Augustin;Kirstin-Benita Banditt

  • Cost of moderate to severe plaque psoriasis in Germany: a multicenter cost-of-illness study.

    S. Sohn;O. Schoeffski;J. Prinz;K. Reich

  • Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): Results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trials

    Mark Lebwohl;Craig Leonardi;Christopher E M Griffiths;Jörg C. Prinz

  • Occurrence of IgE-Bearing Epidermal Langerhans Cells in Atopic Eczema: A Study of the Time Course of the Lesions and With Regard to the IgE Serum Level

    Thomas Bieber;Bernard Dannenberg;Jorg C Prinz;E Peter Rieber

  • Costs and quality of life in patients with moderate to severe plaque-type psoriasis in Germany: a multi-center study.

    Oliver Schöffski;Matthias Augustin;Jörg Prinz;Karin Rauner

Frequent Co-Authors

Klaus Dornmair
Klaus Dornmair Ludwig-Maximilians-Universität München
Johannes Ring
Johannes Ring Technical University of Munich
André Reis
André Reis University of Erlangen-Nuremberg
Frank O. Nestle
Frank O. Nestle Deerfield (United States)
Thomas Bieber
Thomas Bieber University of Bonn
Georg Schett
Georg Schett University of Erlangen-Nuremberg
Heinrich Sticht
Heinrich Sticht University of Erlangen-Nuremberg
Sulev Kõks
Sulev Kõks Perron Institute for Neurological and Translational Science
Wolf-Henning Boehncke
Wolf-Henning Boehncke University of Geneva
Arif B. Ekici
Arif B. Ekici University of Erlangen-Nuremberg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare fields can open diverse career opportunities. Nursing, for instance, offers a practical route into patient care and research collaboration. Many aspiring professionals seek the best online rn programs for non nurses, which provide flexibility and comprehensive training for individuals transitioning into nursing from other backgrounds.

Accelerated pathways are particularly valuable for students who want to enter the nursing field quickly. Programs listed under accelerated nursing programs near me allow candidates to earn their Bachelor of Science in Nursing (BSN) in a shortened timeframe, combining previous education with intensive clinical practice.

For those looking for entry-level credentials, easy admission lpn programs offer a practical option. Licensed Practical Nurses (LPNs) play an essential role in healthcare, providing direct patient care while working closely with registered nurses and immunology specialists.

Advancing beyond nursing roles, becoming a Nurse Practitioner is another viable pathway. Identifying the easiest nurse practitioner program can help streamline entry into this advanced practice, allowing professionals to take on more specialized and leadership roles in both clinical and immunology-related settings.

Best Scientists Citing Jörg C. Prinz

Trending Scientists

Recently Published Articles